1. Home
  2. JOB vs LTRN Comparison

JOB vs LTRN Comparison

Compare JOB & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.25

Market Cap

26.2M

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.14

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOB
LTRN
Founded
1893
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
22.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
JOB
LTRN
Price
$0.25
$3.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
249.5K
282.8K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$96,504,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$1.11
52 Week High
$0.28
$5.74

Technical Indicators

Market Signals
Indicator
JOB
LTRN
Relative Strength Index (RSI) 51.56 70.09
Support Level $0.19 $3.04
Resistance Level $0.27 $3.79
Average True Range (ATR) 0.01 0.30
MACD 0.00 0.10
Stochastic Oscillator 36.64 88.72

Price Performance

Historical Comparison
JOB
LTRN

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: